世界のCOVID-19抗原検査の市場規模は、2023年に110億1000万ドルと評価され、2024年から2030年にかけて-7.8%のCAGRで減少すると予想されます。パンデミックが進行し続け、新たな変異株が出現し、症例数が変動する中、迅速かつ効率的な検査方法が急務となっています。抗原検査は15分から30分以内に結果が出るので、数時間から数日かかる従来のPCR検査に比べて大幅に迅速です。このスピードは、臨床現場、職場、公衆衛生対応におけるタイムリーな意思決定に不可欠です。
目次
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. COVID-19 Antigen Test Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. COVID-19 Antigen Test Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. COVID-19 Antigen Test Market: Product & Service Outlook Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. COVID-19 Antigen Test Market: Product & Service Outlook Movement Analysis, 2023 & 2030 (USD Million)
4.3. Platforms
4.3.1. Platforms Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Reagents & Kits
4.4.1. Reagents & Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Services
4.5.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. COVID-19 Antigen Test Market: End Use Outlook Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. COVID-19 Antigen Test Market: Clinics & Hospitals Movement Analysis, 2023 & 2030 (USD Million)
5.3. Clinics & Hospitals
5.3.1. Clinics & Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Home Care
5.4.1. Home Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Diagnostic Labs
5.5.1. Diagnostic Labs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Others
5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. COVID-19 Antigen Test Market: Regional Estimates & Trend Analysis
6.1. COVID-19 Antigen Test Market Share, By Region, 2023 & 2030 (USD Million)
6.2. North America
6.2.1. North America COVID-19 Antigen Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.2. U.S.
6.2.2.1. U.S. COVID-19 Antigen Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.3. Canada
6.2.3.1. Canada COVID-19 Antigen Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.4. Mexico
6.2.4.1. Mexico COVID-19 Antigen Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3. Europe
6.3.1. Europe COVID-19 Antigen Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.2. U.K.
6.3.2.1. U.K. COVID-19 Antigen Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.3. Germany
6.3.3.1. Germany COVID-19 Antigen Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.4. France
6.3.4.1. France COVID-19 Antigen Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.5. Spain
6.3.5.1. Spain COVID-19 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.6. Italy
6.3.6.1. Italy COVID-19 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.7. Sweden
6.3.7.1. Sweden COVID-19 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.8. Norway
6.3.8.1. Norway COVID-19 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.9. Denmark
6.3.9.1. Denmark COVID-19 Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific COVID-19 Antigen Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.2. China
6.4.2.1. China COVID-19 Antigen Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.3. Japan
6.4.3.1. Japan COVID-19 Antigen Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.4. India
6.4.4.1. India COVID-19 Antigen Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.5. South Korea
6.4.5.1. South Korea COVID-19 Antigen Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.6. Australia
6.4.6.1. Australia COVID-19 Antigen Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.7. Thailand
6.4.7.1. Thailand COVID-19 Antigen Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Latin America
6.5.1. Latin America COVID-19 Antigen Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.2. Brazil
6.5.2.1. Brazil COVID-19 Antigen Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. Argentina
6.5.3.1. Argentina COVID-19 Antigen Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Middle East and Africa
6.6.1. Middle East and Africa COVID-19 Antigen Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.2. Saudi Arabia
6.6.2.1. Saudi Arabia COVID-19 Antigen Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.3. UAE
6.6.3.1. UAE COVID-19 Antigen Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.4. South Africa
6.6.4.1. South Africa COVID-19 Antigen Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.5. Kuwait
6.6.5.1. Kuwait COVID-19 Antigen Test Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
7.4.1. Abbott
7.4.1.1. Participant’s Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Recent Developments/ Strategic Initiatives
7.4.2. SD Biosensor Inc.
7.4.2.1. Participant’s Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Recent Developments/ Strategic Initiatives
7.4.3. Mylab Discovery Solutions Pvt. Ltd
7.4.3.1. Participant’s Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Recent Developments/ Strategic Initiatives
7.4.4. GenBody Inc.
7.4.4.1. Participant’s Overview
7.4.4.2. Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Recent Developments/ Strategic Initiatives
7.4.5. F. Hoffmann-La Roche AG
7.4.5.1. Participant’s Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Recent Developments/ Strategic Initiatives
7.4.6. Access Bio., Inc.
7.4.6.1. Participant’s Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.6.4. Recent Developments/ Strategic Initiatives
7.4.7. ADS biotech Inc.
7.4.7.1. Participant’s Overview
7.4.7.2. Financial Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Recent Developments/ Strategic Initiatives
7.4.8. PerkinElmer, Inc.
7.4.8.1. Participant’s Overview
7.4.8.2. Financial Performance
7.4.8.3. Product Benchmarking
7.4.8.4. Recent Developments/ Strategic Initiatives
7.4.9. Princeton BioMeditech Corporation
7.4.9.1. Participant’s Overview
7.4.9.2. Financial Performance
7.4.9.3. Product Benchmarking
7.4.9.4. Recent Developments/ Strategic Initiatives
7.4.10. Becton, Dickinson, and Company
7.4.10.1. Participant’s Overview
7.4.10.2. Financial Performance
7.4.10.3. Product Benchmarking
7.4.10.4. Recent Developments/ Strategic Initiatives
